evaluate the pharmaceuticals company saxenda on glp-1 drugs for diabetes Saxenda© – A New Treatment Obesity GLP-1 Receptor Agonists – From

JAMA 303 (3), 250257

Domestic US travel: Prescription peptides: Carry prescription, keep in original packaging Research peptides: No specific laws against, but recommend discrete packaging International travel: Prescription peptides: Bring prescription, declare at customs Research peptides: Risk of seizure at customs, laws vary by destination country Recommendation: Don't travel internationally with research peptides (high seizure risk) TSA: Allows peptides in carry-on with syringes for medical use

A: The dosage is as suggested on the packaging

Sun, X., Jiao, X., Ma, Y., Liu, Y., Zhang, L., He, Y., & Chen, Y

Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology

Pooled results demonstrated a significant reduction in weight following LC supplementation, but the subgroups analysis revealed no significant effect of LC on body weight in subjects with body mass index (BMI) below 25 kg/m 2